Acta Scientific Biotechnology

Short Communication Volume 4 Issue 1

Cancer: Diagnosis, Staging, and Complication

Ayesha Javed*

Department of Biotechnology, St. Francis College for Women, India

*Corresponding Author: Ayesha Javed, Department of Biotechnology, St. Francis College for Women, India.

Received: November 28, 2022; Published: December 22, 2022

Introduction

Cancer is one of the biggest causes of death, with more than 10 million mortalities annually, as reported in GLOBOCAN 2020 [1]. The most common types of cancer, according to WHO, are lung, breast, rectum, colon, and prostate cancers [2]. The essential characteristics of cancer are interlaced with an altered cancer-cell intrinsic metabolism, that maybe be the reason or an after-effect [3].

References

  1. Sung H., et al. “Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries”. CA Cancer Journal for Clinicians 3 (2021): 209-249.
  2. Cancer (2022).
  3. Zaimy MA., et al. “New methods in the diagnosis of cancer and gene therapy of cancer-based on nanoparticles”. Cancer Genetic Therapy6 (2017): 233-243.
  4. Turkbey B., et al. “Functional and Molecular Imaging: Applications for Diagnosis and Staging of Localised Prostate Cancer”. Clinical Oncology8 (2013): 451-460.
  5. Siegel DA., et al. “Prostate Cancer Incidence and Survival, by Stage and Race/Ethnicity — United States, 2001-2017” (2020).
  6. Sung H., et al. “Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries”. CA Cancer Journal for Clinicians3 (2021): 209-249.
  7. Barba D., et al. “Breast cancer, screening and diagnostic tools: All you need to know”. Critical Reviews in Oncology/Hematology 157 (2021): 103174.
  8. Wu L and Qu X. “Cancer biomarker detection: recent achievements and challenges”. Chemical Society Reviews 10 (2015): 2963-2997.
  9. Wadowska K., et al. “Genetic Markers in Lung Cancer Diagnosis: A Review”. International Journal of Molecular Sciences 21 (2020): 4569.
  10. Hasan S., et al. “Advances in pancreatic cancer biomarkers”. Oncology Review1 (2019): 69-76.
  11. Chaturvedi VK., et al. “Cancer Nanotechnology: A New Revolution for Cancer Diagnosis and Therapy”. Current Drug Metabolism 6 (2019): 416-429.
  12. Zhang Y., et al. “Nanotechnology in cancer diagnosis: progress, challenges and opportunities”. Journal of Hematology and Oncology 1 (2019): 137.
  13. Kabir KMM and Donald WA. “Cancer breath testing: a patent review”. Expert Opinion on Therapeutic Patents3 (2018).
  14. Tian X., et al. “CRISPR/Cas9-An evolving biological tool kit for cancer biology and oncology”. npj Precision Oncology 8 (2019).
  15. Saba T. “Recent advancement in cancer detection using machine learning: Systematic survey of decades, comparisons and challenges”. Journal of Infection and Public Health 9 (2020): 1274-1289.
  16. Wu D., et al. “Cancer bioinformatics: A new approach to systems clinical medicine” (2012).
  17. Vandenbrouck Y., et al. “Bioinformatics Tools and Workflow to Select Blood Biomarkers for Early Cancer Diagnosis: An Application to Pancreatic Cancer”. Proteomics 21-22 (2019): 1800489.
  18. Surman M and Janik ME. “Stress and its molecular consequences in cancer progression”. Postepy higieny I Medycyny Doswiadczalnej (Online) 71 (2017): 485-499.

Citation

Citation: Ayesha Javed. “Cancer: Diagnosis, Staging, and Complication".Acta Scientific Biotechnology 4.1 (2023): 20-22.

Copyright

Copyright: © 2022 Ayesha Javed. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.




Metrics

Acceptance rate33%
Acceptance to publication20-30 days

Indexed In



News and Events


  • Certification for Review
    Acta Scientific certifies the Editors/reviewers for their review done towards the assigned articles of the respective journals.
  • Submission Timeline for Upcoming Issue
    The last date for submission of articles for regular Issues is May 30, 2024.
  • Publication Certificate
    Authors will be issued a "Publication Certificate" as a mark of appreciation for publishing their work.
  • Best Article of the Issue
    The Editors will elect one Best Article after each issue release. The authors of this article will be provided with a certificate of "Best Article of the Issue"
  • Welcoming Article Submission
    Acta Scientific delightfully welcomes active researchers for submission of articles towards the upcoming issue of respective journals.

Contact US